Preview

Current Pediatrics

Advanced search

Combination of Psoriasis and Vitiligo in a Child with Sotos Syndrome: Clinical Case

https://doi.org/10.15690/vsp.v23i2.2742

Abstract

Background. Psoriasis and vitiligo are chronic, relatively common dermatological diseases. Meanwhile, their combination in children is rare. The combination of psoriasis and vitiligo in a child with Sotos syndrome has not been previously described. Clinical case description. The boy, 10 years old, was hospitalized with complaints (according to his mother) of rashes on the scalp, body, and limbs, with mild itching that was not related to the time of day. The pathological skin process was widespread. The patient was hyperactive, restless, emotionally labile, irritable. Complaints of rashes was mentioned firstly at the age of 7. Sotos syndrome was established at the age of 8 (variant c.6559C>T (p.Arg2187Ter) in 23 exon of the NSD1 gene (5q35.3), autosomal dominant type of inheritance (pathological allele de novo)). Psoriasis vulgaris was diagnosed with secondary vitiligo (localized form) at the age of 8.5 years. Symptomatic antipruritic and external pathogenetic therapy was performed in the hospital. Phototherapy was not prescribed due to the relative contradiction (small retrocerebral cyst) and the peculiarities of major disease (hyperactivity, restlessness) that complicated to place the child in the phototherapy booth. Positive dynamics was noted during the treatment (14 days): no itching, decrease of peeling severity, flattening and blanching of psoriatic rash elements to spots of post-inflammatory hypopigmentation. The lesion (focus of depigmentation) on the right knee joint skin remained unchanged. The patient was discharged to outpatient care. The prognosis for Sotos syndrome and skin lesions is favorable. Conclusion. The first medical observation of the child with Sotos syndrome burdened with psoriasis and vitiligo is presented. The pathogenetic correlation of these diseases is not clearly defined. Management of such cases requires the joint collaboration of dermatologists, geneticists and pediatricians.

About the Authors

Elena N. Efanova
Surgut State University
Russian Federation

Surgut


Disclosure of interest:

None



Daria G. Taskaeva
Surgut State University
Russian Federation

Surgut


Disclosure of interest:

None



References

1. Wang X, Yeh S, Wu G, et al. Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells. J Biol Chem. 2001;276(44):40417-40423. doi: https://doi.org/10.1074/jbc.M104765200

2. Malan V, Rajan D, Thomas S, et al. Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. Am J Hum Genet. 2010;87(2):189-198. doi: https://doi.org/10.1016/j.ajhg.2010.07.001

3. Tatton-Brown K, Rahman N. Sotos syndrome. Eur J Hum Genet. 2007;15:264-271. doi: https://doi.org/10.1038/sj.ejhg.5201686

4. Tatton-Brown K, Rahman N. The NSD1 and EZH2 overgrowth genes, similarities and differences. Am J Med Genet C Semin Med Genet. 2013;163C(2):86-91. doi: https://doi.org/10.1002/ajmg.c.31359

5. Tatton-Brown K, Douglas J, Coleman K, et al. Childhood Overgrowth Collaboration Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet. 2005;77(2):193-204. doi: https://doi.org/10.1086/432082

6. Dahlqvist P, Spencer R, Marques P, et al. Pseudoacromegaly: a differential diagnostic problem for acromegaly with a genetic solution. J Endocr Soc. 2017;1(8):1104-1109. doi: https://doi.org/10.1210/js.2017-00164

7. Douglas J, Hanks S, Temple IK, et al. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet. 2003;72(1):132-143. doi: https://doi.org/10.1086/345647

8. Carapito R, Isidor B, Guerouaz N, et al. Homozygous IL36RN mutation and NSD1 duplication in a patient with severe pustular psoriasis and symptoms unrelated to deficiency of interleukin-36 receptor antagonist. Br J Dermatol. 2015;172(1):302-305. doi: https://doi.org/10.1111/bjd.13261

9. Kridin K, Lyakhovitsky K, Onn E, et al. Investigating the epidemiological relationship between vitiligo and psoriasis: a population-based study. Arch Dermatol Res. 2023;315(3): 395-400. doi: https://doi.org/10.1007/s00403-022-02358-8

10. Burlando M, Muracchioli A, Cozzani E, Parodi A. Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review. Case Rep Dermatol. 2021;13(2):372-378. doi: https://doi.org/10.1159/000514198

11. Psoriaz: Clinical recommendations. Russian Society of Dermatovenerologists and Cosmetologists. 2023. 78 p. (In Russ).

12. Vitiligo: Clinical guidelines. Russian Society of Dermatovenerologists and Cosmetologists. 2016. 18 p. (In Russ).

13. Krenitsky A, Ghamrawi RI, Feldman SR. Phototherapy: a Review and Update of Treatment Options in Dermatology. Curr Derm Rep. 2020;9:10-21. doi: https://doi.org/10.1007/s13671-020-00290-6

14. Nada HR, El Sharkawy DA, Elmasry MF, et al. Expression of Janus Kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study. Arch Dermatol Res. 2018;310(1):39-46. doi: https://doi.org/10.1007/s00403-017-1792-6

15. Piskin G, Tursen U, Sylva-Steenland RM, et al. Clinical improvement in chronic plaque-type psoriasis lesions after narrowband UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers — IL-12, IL-18 and IL-23. Exp Dermatol. 2004;13(12):764-772. doi: https://doi.org/10.1111/j.0906-6705.2004.00246.x


Review

For citations:


Efanova E.N., Taskaeva D.G. Combination of Psoriasis and Vitiligo in a Child with Sotos Syndrome: Clinical Case. Current Pediatrics. 2024;23(2):111-115. (In Russ.) https://doi.org/10.15690/vsp.v23i2.2742

Views: 482


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)